Skip to content

Aurobindo Pharma subsidiary gets Brazil regulator nod for Hyderabad biosimilars facility

Shares of Aurobindo Pharma Ltd ended at ₹1,570.90, up by ₹10.35, or 0.66%, on the BSE.​Read More

Leave a Reply

Your email address will not be published. Required fields are marked *